Capital Fund Management (CFM)’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-12,400
| Closed | -$2.15M | – | 2164 |
|
|
2025
Q4 | $2.15M | Sell |
12,400
-4,300
| -26% | -$783K | 0.01% | 1671 |
|
|
2025
Q3 | $3.18M | Buy |
16,700
+4,100
| +33% | +$728K | 0.01% | 1531 |
|
|
2025
Q2 | $2.26M | Buy |
+12,600
| New | +$2.19M | 0.01% | 1603 |
|
|
2024
Q1 | – | Sell |
-16,300
| Closed | -$2.25M | – | 2028 |
|
|
2023
Q4 | $2.25M | Buy |
+16,300
| New | +$2.14M | 0.01% | 1477 |
|
|
2022
Q2 | – | Sell |
-15,000
| Closed | -$2.05M | – | 1477 |
|
|
2022
Q1 | $2.05M | Sell |
15,000
-15,700
| -51% | -$2.19M | 0.02% | 941 |
|
|
2021
Q4 | $5.31M | Buy |
30,700
+5,400
| +21% | +$822K | 0.04% | 616 |
|
|
2021
Q3 | $3.68M | Buy |
25,300
+12,900
| +104% | +$1.89M | 0.03% | 692 |
|
|
2021
Q2 | $1.64M | Sell |
12,400
-8,400
| -40% | -$1.1M | 0.01% | 1012 |
|
|
2021
Q1 | $2.67M | Sell |
20,800
-10,400
| -33% | -$1.28M | 0.03% | 649 |
|
|
2020
Q4 | $3.72M | Buy |
+31,200
| New | +$3.8M | 0.04% | 569 |
|
|
2020
Q3 | – | Sell |
-19,200
| Closed | -$2.19M | – | 1234 |
|
|
2020
Q2 | $2.19M | Buy |
+19,200
| New | +$2.04M | 0.03% | 472 |
|
|
2020
Q1 | – | Sell |
-2,400
| Closed | -$256K | – | 1641 |
|
|
2019
Q4 | $256K | Sell |
2,400
-18,600
| -89% | -$1.94M | ﹤0.01% | 1656 |
|
|
2019
Q3 | $2.25M | Buy |
21,000
+10,500
| +100% | +$1.08M | 0.02% | 750 |
|
|
2019
Q2 | $1.07M | Buy |
+10,500
| New | +$1.01M | 0.01% | 996 |
|
|
2018
Q1 | – | Sell |
-3,000
| Closed | -$295K | – | 1891 |
|
|
2017
Q4 | $295K | Sell |
3,000
-1,900
| -39% | -$180K | ﹤0.01% | 1627 |
|
|
2017
Q3 | $459K | Buy |
4,900
+2,600
| +113% | +$276K | ﹤0.01% | 1199 |
|
|
2017
Q2 | $256K | Buy |
+2,300
| New | +$243K | ﹤0.01% | 1321 |
|
|
2017
Q1 | – | Sell |
-2,700
| Closed | -$248K | – | 1536 |
|
|
2016
Q4 | $248K | Sell |
2,700
-3,200
| -54% | -$276K | ﹤0.01% | 1501 |
|
|
2016
Q3 | $499K | Buy |
+5,900
| New | +$495K | ﹤0.01% | 1201 |
|
|
2016
Q1 | – | Sell |
-3,200
| Closed | -$228K | – | 1585 |
|
|
2015
Q4 | $228K | Sell |
3,200
-1,600
| -33% | -$108K | ﹤0.01% | 1415 |
|
|
2015
Q3 | $295K | Sell |
4,800
-17,400
| -78% | -$1.22M | ﹤0.01% | 1218 |
|
|
2015
Q2 | $1.61M | Buy |
22,200
+13,300
| +149% | +$982K | 0.02% | 692 |
|
|
2015
Q1 | $684K | Buy |
+8,900
| New | +$637K | 0.01% | 922 |
|
|
2014
Q3 | – | Sell |
-4,100
| Closed | -$241K | – | 1569 |
|
|
2014
Q2 | $241K | Buy |
+4,100
| New | +$240K | ﹤0.01% | 1517 |
|
Other funds holding DGX
VCM
VPM
EIG
Capital Fund Management (CFM)'s DGX Position: Q1 2026 in Review
Capital Fund Management (CFM) opened a new position in Quest Diagnostics (DGX) in Q1 2026: 26,563 shares worth $5.21M. The stake represents 0.02% of the portfolio and ranks #874 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in DGX as recently as Q3 2025.
Capital Fund Management (CFM) first reported a position in DGX in Q2 2013 and has held it in 30 quarters since. The position peaked at $35.8M in Q4 2017. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Capital Fund Management (CFM) held 26,563 shares of Quest Diagnostics worth $5.21M as of Q1 2026.
- Quest Diagnostics was a new Capital Fund Management (CFM) position in Q1 2026.
- Quest Diagnostics made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #874 holding.
- Capital Fund Management (CFM) first reported a position in Quest Diagnostics in Q2 2013 and has held it in 30 quarters since.
- Capital Fund Management (CFM)'s Quest Diagnostics position peaked at $35.8M in Q4 2017.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.